David R. Purdue - 01 Mar 2025 Form 3 Insider Report for AbbVie Inc. (ABBV)

Role
SVP, Controller
Signature
/s/ T.O. Odutayo, Attorney-in-Fact for David R. Purdue
Issuer symbol
ABBV
Transactions as of
01 Mar 2025
Transactions value $
$0
Form type
3
Filing time
10 Mar 2025, 16:28:43 UTC
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ABBV Common Stock, $0.01 par value 4.51K 01 Mar 2025 Direct
holding ABBV Common Stock, $0.01 par value 527 01 Mar 2025 Profit sharing trust F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ABBV Option (Right to buy) 01 Mar 2025 Common Stock 3.38K $149.62 Direct F2
holding ABBV Option (Right to buy) 01 Mar 2025 Common Stock 5.36K $175.28 Direct F3
holding ABBV Option (Right to buy) 01 Mar 2025 Common Stock 5.21K $192.86 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Balance in AbbVie Savings Program as of March 1, 2025. Balance includes shares acquired pursuant to a dividend reinvestment feature.
F2 Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program. The option became exercisable as to 1,126 shares on 02/16/2024, as to 1,125 shares on 02/16/2025, and will become exercisable as to 1,125 shares on 02/16/2026.
F3 Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program. The option became exercisable as to 1,786 shares on 02/15/2025, and will become exercisable as to 1,786 shares on 02/15/2026, and as to 1,786 shares on 02/15/2027.
F4 Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program. The option becomes exercisable as to 1,736 shares on 02/13/2026, as to 1,736 shares on 02/13/2027, and as to 1,736 shares on 02/13/2028.